Patents/Assignees

SHENZHEN HWAGEN PHARMACEUTICAL CO., Ltd.

1 patent in portfolio

US12559484utility2026
Route for Constructing Chiral Fragment of Fezolinetant, Intermediate Thereof, and Preparation Method Therefor
0 cites